Northern Trust Corp Moon Lake Immunotherapeutics Transaction History
Northern Trust Corp
- $690 Billion
- Q4 2024
A detailed history of Northern Trust Corp transactions in Moon Lake Immunotherapeutics stock. As of the latest transaction made, Northern Trust Corp holds 14,261 shares of MLTX stock, worth $580,850. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,261
Previous 5,450
161.67%
Holding current value
$580,850
Previous $274,000
176.28%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding MLTX
# of Institutions
136Shares Held
58.1MCall Options Held
124KPut Options Held
96.9K-
Bvf Inc San Francisco, CA19.8MShares$804 Million39.28% of portfolio
-
Cormorant Asset Management, LP Boston, MA8.49MShares$346 Million35.64% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.34MShares$136 Million0.02% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.77MShares$113 Million2.15% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.19MShares$89.1 Million0.02% of portfolio
About MoonLake Immunotherapeutics
- Ticker MLTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,925,600
- Market Cap $1.5B
- Description
- MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or rad...